World's Best Scientists 2026 revealed!

D-Index & Metrics

Genetics

D-Index
48
Citations
10183
World Ranking
4052
National Ranking
147

Klaas Kok publication distribution in Genetics in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Genetics in 2026. The highlighted bar marks where Klaas Kok sits on this spectrum.

45–54 publications: 6 scientists 55–64 publications: 10 scientists 65–74 publications: 35 scientists 75–84 publications: 84 scientists 85–94 publications: 102 scientists 95–104 publications: 151 scientists 105–114 publications: 175 scientists 115–124 publications: 203 scientists 125–134 publications: 217 scientists 135–144 publications: 205 scientists 145–154 publications: 193 scientists 155–164 publications: 188 scientists 165–174 publications: 170 scientists 175–184 publications: 178 scientists 185–194 publications: 164 scientists 195–204 publications: 173 scientists 205–214 publications: 159 scientists 215–224 publications: 134 scientists 225–234 publications: 143 scientists 235–244 publications: 105 scientists 245–254 publications: 114 scientists 255–264 publications: 92 scientists 265–274 publications: 88 scientists 275–284 publications: 87 scientists 285–294 publications: 80 scientists 295–304 publications: 62 scientists 305–314 publications: 75 scientists 315–324 publications: 67 scientists 325–334 publications: 60 scientists 335–344 publications: 52 scientists 345–354 publications: 40 scientists 355–364 publications: 48 scientists 365–374 publications: 47 scientists 375–384 publications: 46 scientists 385–394 publications: 31 scientists 395–404 publications: 27 scientists 405–414 publications: 40 scientists 415–424 publications: 30 scientists 425–434 publications: 43 scientists 435–444 publications: 29 scientists 445–454 publications: 14 scientists 455–464 publications: 28 scientists 465–474 publications: 21 scientists 475–484 publications: 21 scientists 485–494 publications: 22 scientists 495–504 publications: 17 scientists 505–514 publications: 12 scientists 515–524 publications: 11 scientists 525–534 publications: 8 scientists 535–544 publications: 8 scientists 545–554 publications: 14 scientists 555–564 publications: 4 scientists 565–574 publications: 11 scientists 575–584 publications: 5 scientists 585–594 publications: 11 scientists 595–604 publications: 12 scientists 605–614 publications: 7 scientists 615–624 publications: 6 scientists 625–634 publications: 10 scientists 635–644 publications: 9 scientists 645–654 publications: 10 scientists 655–664 publications: 6 scientists 665–674 publications: 6 scientists 675–684 publications: 6 scientists 685–694 publications: 4 scientists 695–702 publications: 6 scientists 703+ publications: 100 scientists
45 publications 703+

This scientist: 245 publications — 65th percentile

65% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 703 publications or more.

Klaas Kok D-index placement in Genetics in 2026

The chart shows the D-index (discipline H-index) distribution of Genetics scientists ranked by Research.com in 2026. The highlighted bar marks where Klaas Kok sits on this spectrum.

40–41 D-Index: 24 scientists 42–43 D-Index: 52 scientists 44–45 D-Index: 84 scientists 46–47 D-Index: 112 scientists 48–49 D-Index: 118 scientists 50–51 D-Index: 141 scientists 52–53 D-Index: 143 scientists 54–55 D-Index: 145 scientists 56–57 D-Index: 179 scientists 58–59 D-Index: 162 scientists 60–61 D-Index: 175 scientists 62–63 D-Index: 191 scientists 64–65 D-Index: 172 scientists 66–67 D-Index: 184 scientists 68–69 D-Index: 164 scientists 70–71 D-Index: 158 scientists 72–73 D-Index: 150 scientists 74–75 D-Index: 136 scientists 76–77 D-Index: 127 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 111 scientists 82–83 D-Index: 110 scientists 84–85 D-Index: 110 scientists 86–87 D-Index: 84 scientists 88–89 D-Index: 102 scientists 90–91 D-Index: 66 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 70 scientists 96–97 D-Index: 54 scientists 98–99 D-Index: 60 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 55 scientists 104–105 D-Index: 45 scientists 106–107 D-Index: 42 scientists 108–109 D-Index: 28 scientists 110–111 D-Index: 39 scientists 112–113 D-Index: 25 scientists 114–115 D-Index: 31 scientists 116–117 D-Index: 29 scientists 118–119 D-Index: 34 scientists 120–121 D-Index: 29 scientists 122–123 D-Index: 29 scientists 124–125 D-Index: 18 scientists 126–127 D-Index: 27 scientists 128–129 D-Index: 22 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 11 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 12 scientists 138–139 D-Index: 21 scientists 140–141 D-Index: 4 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 14 scientists 146–147 D-Index: 6 scientists 148–149 D-Index: 10 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 9 scientists 154–155 D-Index: 8 scientists 156–157 D-Index: 8 scientists 158–159 D-Index: 9 scientists 160+ D-Index: 96 scientists
40 D-Index 160+

This scientist: 48 D-Index — 8th percentile

8% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 160 D-Index or more.

Overview

Klaas Kok is affiliated with the University of Groningen in the Netherlands. Their research spans key fields in Medicine and Biochemistry, Genetics and Molecular Biology, focusing notably on Cancer Research, Pulmonary and Respiratory Medicine, Oncology, Molecular Biology, and Pathology and Forensic Medicine.

Their recent scientific publications include:

  • Cellular senescence impairs the reversibility of pulmonary arterial hypertension, 2020, Science Translational Medicine
  • Establishment and characterisation of testicular cancer patient-derived xenograft models for preclinical evaluation of novel therapeutic strategies, 2020, Scientific Reports
  • Combined osimertinib, dabrafenib and trametinib treatment for advanced non-small-cell lung cancer patients with an osimertinib-induced BRAF V600E mutation, 2020, Lung Cancer
  • Extracellular Vesicles Enriched in hsa-miR-301a-3p and hsa-miR-1293 Dynamics in Clear Cell Renal Cell Carcinoma Patients: Potential Biomarkers of Metastatic Disease, 2020, Cancers
  • An mRNA expression-based signature for oncogene-induced replication-stress, 2022, Oncogene

Frequent co-authors contributing to Klaas Kok's collaborative works include:

  • Anke van den Berg
  • Harry J.M. Groen
  • T. Jeroen N. Hiltermann
  • Anthonie J. van der Wekken
  • Miente Martijn Terpstra

The scientist's publications have appeared predominantly in the following venues:

  • Cancers
  • Scientific Reports
  • Frontiers in Oncology
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Journal of Ovarian Research

Klaas Kok's research addresses multiple topics within their fields, including:

  • Lung Cancer Treatments and Mutations
  • Cancer Genomics and Diagnostics
  • Lung Cancer Research Studies
  • MicroRNA in disease regulation
  • Lymphoma Diagnosis and Treatment
  • Colorectal Cancer Treatments and Studies
  • Synthesis and biological activity

The body of work contributed by Klaas Kok includes 54 publications in Medicine and 36 in Biochemistry, Genetics and Molecular Biology. Of these, 20 relate to Cancer Research, 18 each to Pulmonary and Respiratory Medicine and Oncology, 16 to Molecular Biology, and 7 to Pathology and Forensic Medicine.

Best Publications

  • Consensus Statement : Chromosomal Microarray Is a First-Tier Clinical Diagnostic Test for Individuals with Developmental Disabilities or Congenital Anomalies

    David T. Miller;Margaret P. Adam;Margaret P. Adam;Swaroop Aradhya;Leslie G. Biesecker

  • Deletion of a DNA sequence at the chromosomal region 3p21 in all major types of lung cancer

    Klaas Kok;Jan Osinga;Ben Carritt;Mary B. Davis

  • Deletions of the short arm of chromosome 3 in solid tumors and the search for suppressor genes

    Klaas Kok;Susan L. Naylor;Charles H.C.M. Buys

  • Histone methyltransferase gene SETD2 is a novel tumor suppressor gene in clear cell renal cell carcinoma.

    Gerben Duns;Eva van den Berg;Inge van Duivenbode;Jan Osinga

  • p53 Mutations in Human Lung Tumors

    C. W. Miller;K. Simon;A. Aslo;K. Kok

  • Gene amplification as double minutes or homogeneously staining regions in solid tumors: Origin and structure

    Clelia Tiziana Storlazzi;Angelo Lonoce;Maria C. Guastadisegni;Domenico Trombetta

  • Nine patients with a microdeletion 15q11.2 between breakpoints 1 and 2 of the Prader-Willi critical region, possibly associated with behavioural disturbances.

    Marianne Doornbos;Birgit Sikkema-Raddatz;Claudia A. L. Ruijvenkamp;Trijnie Dijkhuizen

  • Isolation of the human semaphorin III/F gene (SEMA3F) at chromosome 3p21, a region deleted in lung cancer.

    Rui-Hua Xiang;Charles H. Hensel;Dawn K. Garcia;Helene C. Carlson

  • SETD2: an epigenetic modifier with tumor suppressor functionality

    Jun Li;Gerben Duns;Helga Westers;Rolf Sijmons

  • Genotype-phenotype correlation in 21 patients with Wolf-Hirschhorn syndrome using high resolution array comparative genome hybridisation (CGH)

    N. M. C. Maas;G. Van Buggenhout;F. Hannes;B. Thienpont

  • A high throughput experimental approach to identify miRNA targets in human cells

    Lu Ping Tan;Erwin Seinen;Gerben Duns;Debora de Jong

  • A GENE IN THE CHROMOSOMAL REGION 3P21 WITH GREATLY REDUCED EXPRESSION IN LUNG-CANCER IS SIMILAR TO THE GENE FOR UBIQUITIN-ACTIVATING ENZYME

    Klaas Kok;Robert Hofstra;A Pilz;van den Anke Berg

  • Resistance mechanisms after tyrosine kinase inhibitors afatinib and crizotinib in non-small cell lung cancer, a review of the literature

    A.J. van der ->Wekken;A. Saber;T.J.N. Hiltermann;K. Kok

  • A homozygous deletion in a small cell lung cancer cell line involving a 3p21 region with a marked instability in yeast artificial chromosomes

    K Kok;Anke van den Berg;Pmjf Veldhuis;Ay Vanderveen

  • Genomic organization and evolution of double minutes/homogeneously staining regions with MYC amplification in human cancer

    Alberto L'Abbate;Gemma Macchia;Pietro D'Addabbo;Angelo Lonoce

  • Practical guidelines for interpreting copy number gains detected by high-resolution array in routine diagnostics.

    Nicolien M Hanemaaijer;Birgit Sikkema-Raddatz;Gerben van der Vries;Trijnie Dijkhuizen

  • Cellular senescence impairs the reversibility of pulmonary arterial hypertension.

    Diederik E. van der Feen;Guido P.L. Bossers;Quint A.J. Hagdorn;Jan Renier Moonen

  • Genome-Wide Arrays: Quality Criteria and Platforms to be Used in Routine Diagnostics

    Joris R. Vermeesch;Paul D. Brady;Damien Sanlaville;Damien Sanlaville;Klaas Kok

  • Establishment and characterisation of testicular cancer patient-derived xenograft models for preclinical evaluation of novel therapeutic strategies.

    Gerda de Vries;Ximena Rosas-Plaza;Gert Jan Meersma;Vincent C. Leeuwenburgh

  • Amplicon mapping and expression profiling identify the fas-associated death domain gene as a new driver in the 11q13.3 amplicon in Laryngeal/Pharyngeal cancer

    Johan H. Gibcus;Lorian Menkema;Mirjam F. Mastik;Mario A. Hermsen

Frequent Co-Authors

Anke van den Berg
Anke van den Berg University Medical Center Groningen
Charles H.C.M. Buys
Charles H.C.M. Buys University of Groningen
Harry J.M. Groen
Harry J.M. Groen University Medical Center Groningen
Wim Timens
Wim Timens University Medical Center Groningen
Ed Schuuring
Ed Schuuring University Medical Center Groningen
Rolf H. Sijmons
Rolf H. Sijmons University of Groningen
Robert M.W. Hofstra
Robert M.W. Hofstra Erasmus University Rotterdam
Sibrand Poppema
Sibrand Poppema Sunway University
Philip M. Kluin
Philip M. Kluin University Medical Center Groningen
Ilja M. Nolte
Ilja M. Nolte University Medical Center Groningen

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Genetics can open doors to a range of healthcare and science-related careers. Many students explore flexible online options for advancing their education or entering allied health fields. For example, nurses aiming to expand their qualifications while balancing work might consider rn to bsn programs with no clinicals—these can save valuable time and minimize on-site requirements.

For those interested in doctoral-level leadership, there are fastest dnp program online options and dnp programs online that are designed for working professionals seeking advanced practice roles. These programs can often be completed in a short period and may offer more accessible admissions criteria.

Alternatively, students looking for a quicker entry into the healthcare workforce might consider a medical assistant training program. These accelerated pathways provide foundational skills and credentials, often within just a few weeks, making it easier to start working sooner.

By exploring these diverse online degrees and pathways, students in Genetics can find study options that align with their career ambitions, schedules, and learning preferences.

Best Scientists Citing Klaas Kok

Trending Scientists

Recently Published Articles